ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Markets/EquitiesArticle

Nike shares near 52-week low amid valuation debate after 47% annual slide

Stock at $40.75, down 47% over 12 months, with analysts divided on whether the selloff has created a buying opportunity. Stifel and Jefferies set price targets of $64 and $115 respectively.

PA
Priya Anand · Equities & Earnings Desk · 29 Aug 2026 · 03:32 · 1 min read
Share
Nike shares near 52-week low amid valuation debate after 47% annual slide

Nike Inc. shares are trading within 5% of their 52-week low of $38.86, having fallen 47% over the past year to $40.75 as of Tuesday. The decline follows a sharp drop in profitability and a slowdown in revenue growth, with net income falling 49% from $6.05 billion in fiscal 2022 to an estimated $3.11 billion in fiscal 2026.

The company’s trailing price-to-earnings ratio has compressed to 19.5x from 12.9% net margins in prior periods, while the forward P/E stands at 23.7x. Analysts at Stifel and Jefferies have set respective price targets of $64 and $115, implying upside potential of 45% and 183% from current levels. Stifel cited a survey showing Nike’s brand popularity recovered to 45.8% from an all-time low of 38.2%, though still well below its 2021 peak of 92.5%. The rebound was attributed to the Air Force 1 franchise, which has maintained popularity for eight consecutive years.

Revenue peaked at $51.4 billion in fiscal 2024 before declining to an estimated $46.4 billion in fiscal 2026. Net margins have nearly halved from 12.9% to 6.7%, while earnings per share growth turned negative at -3.1%. The China market, a key growth driver, reported a 26% year-over-year decline in digital sales in the most recent quarter.

Despite the challenges, Nike maintains a strong balance sheet with a current ratio of 2.0x and a dividend yield of 4%, marking the 23rd consecutive year of dividend increases. The stock’s monthly relative strength index stands at 29.6, indicating deeply oversold conditions. However, the company’s innovation pipeline is not expected to reach scale until fiscal 2027–28, with the next major catalyst set for November’s Investor Day.

Analysts remain divided on whether the selloff represents a value trap or a potential entry point, with valuation metrics and long-term growth prospects remaining key points of contention.

This article was produced with AI assistance and edited by a Finance Review Daily journalist.
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets
Share this story
PA
Written by
Priya Anand
Equities & Earnings Desk

Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.

More from Priya Anand →
ADVERTISEMENT
ADVERTISEMENT